(Q41415279)

30 September 2017

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels (English)

1 reference

30 September 2017

1 reference

G Bertelli

1

1 reference

30 September 2017

P Pronzato

2

1 reference

30 September 2017

D Amoroso

3

1 reference

30 September 2017

M P Cusimano

4

1 reference

30 September 2017

P F Conte

5

1 reference

30 September 2017

G Montagna

6

1 reference

30 September 2017

S Bertolini

7

1 reference

30 September 2017

R Rosso

8

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

Breast Cancer Research and Treatment

30 September 2017

1 reference

30 September 2017

12

1 reference

30 September 2017

3

1 reference

30 September 2017

307-310

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01811244

30 September 2017

0 references

cites work

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Tamoxifen treatment of metastatic breast cancer and antithrombin III levels

1 reference

12 December 2020

Venous thrombosis as a side effect of tamoxifen treatment

1 reference

12 December 2020

Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III

1 reference

12 December 2020

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen

1 reference

12 December 2020

Tamoxifen and thromboembolism

1 reference

12 December 2020

Tamoxifen and thrombosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01811244

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference